CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells

Published:2020-10 Issue: Volume:130 Page:110544
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Sun Jing-yi,Hou Ya-jun,Yin Yi-bo,Wang Feng-ze,Yang Ming-feng,Zhang Yuan-ying,Fan Cun-dong,Sun Bao-liang

Funder

National Natural Science Foundation of China

Academic Promotion Programme of Shandong First Medical University ＆ Shandong Academy of Medical Sciences

Shandong Introduction and Education Program of Young Innovative Talents

Science and Technology Project of Universities in Shandong

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference30 articles.

1. MiR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9;Wang;Biomed. Pharmacother.,2018

2. Arene ruthenium(ii) complexes induce S-phase arrest in MG-63 cells through stabilization of c-Myc G-quadruplex DNA;Fan;Medchemcomm.,2014

3. Recent advances in osteosarcoma;Botter;Curr. Opin. Pharmacol.,2014

4. Osteosarcoma treatment - where do we stand? A state of the art review;Luetke;Cancer Treat. Rev.,2014

5. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis;Chen;J. Cancer Res. Clin. Oncol.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines;Biomedicines;2023-08-28

2. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies;MedComm;2023-07-10

3. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

4. Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials;Pharmacological Research;2022-09

5. The roles of glycolysis in osteosarcoma;Frontiers in Pharmacology;2022-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3